John Vieceli Sells 15,112 Shares of Quantum-Si (NASDAQ:QSI) Stock

Quantum-Si Incorporated (NASDAQ:QSI) insider John Vieceli sold 15,112 shares of the business’s stock in a transaction on Tuesday, June 23rd. The shares were sold at an average price of $0.90, for a total transaction of $13,600.80. Following the completion of the sale, the insider directly owned 1,140,434 shares in the company, valued at $1,026,390.60. This trade represents a 1.31% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Quantum-Si Trading Down 6.0%

NASDAQ:QSI traded down $0.05 during mid-day trading on Wednesday, hitting $0.83. The company’s stock had a trading volume of 5,042,480 shares, compared to its average volume of 6,078,957. The company has a market capitalization of $180.13 million, a price-to-earnings ratio of -1.62 and a beta of 3.18. Quantum-Si Incorporated has a fifty-two week low of $0.69 and a fifty-two week high of $3.10. The stock has a fifty day moving average of $0.99 and a 200-day moving average of $1.04.

Quantum-Si (NASDAQ:QSI) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.10) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.02. Quantum-Si had a negative return on equity of 47.35% and a negative net margin of 5,605.88%.The company had revenue of $0.26 million for the quarter, compared to the consensus estimate of $0.30 million. On average, equities analysts anticipate that Quantum-Si Incorporated will post -0.49 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Canaccord Genuity Group decreased their price target on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, March 4th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and a consensus target price of $1.00.

Hedge Funds Weigh In On Quantum-Si

A number of institutional investors and hedge funds have recently added to or reduced their stakes in QSI. Vanguard Group Inc. boosted its position in Quantum-Si by 0.5% in the third quarter. Vanguard Group Inc. now owns 8,714,507 shares of the company’s stock valued at $12,287,000 after buying an additional 44,846 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Quantum-Si by 9.8% during the fourth quarter. Geode Capital Management LLC now owns 4,114,375 shares of the company’s stock worth $4,527,000 after buying an additional 367,206 shares in the last quarter. Millennium Management LLC bought a new position in shares of Quantum-Si in the first quarter valued at approximately $4,721,000. State Street Corp boosted its holdings in shares of Quantum-Si by 26.5% in the 4th quarter. State Street Corp now owns 3,562,721 shares of the company’s stock worth $3,919,000 after acquiring an additional 745,231 shares in the last quarter. Finally, Squarepoint Ops LLC acquired a new position in shares of Quantum-Si in the 3rd quarter worth approximately $865,000. 39.90% of the stock is currently owned by institutional investors and hedge funds.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.